Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Auto-summary of recent filing activity and financial trends · not investment advice
A review of Eli Lilly's (LLY) recent SEC EDGAR filing activities shows that Form 4 filings, related to insider trading, were the most frequent with 20 submissions. There were 3 Form 8-K filings, which report significant events, and one Form 10-Q (quarterly report) and one Form DEF 14A (definitive proxy statement) were also submitted. The provided data does not include information on revenue and net income trends, making it difficult to ascertain financial trends.
Latest filings collected from EDGAR
